Pathophysiology, diagnosis, and management of hepatic encephalopathy

被引:10
作者
Sheasgreen, Christopher [1 ]
Lu, Lucy [1 ]
Patel, Ameen [1 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
关键词
Hepatic encephalopathy; Ammonia; Lactulose; Antibiotics; PORTAL-SYSTEMIC ENCEPHALOPATHY; RANDOMIZED CONTROLLED-TRIAL; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; LIVER-DISEASE; CIRRHOTIC-PATIENTS; ALBUMIN DIALYSIS; AMMONIA LEVELS; SECONDARY PROPHYLAXIS; NITROGEN-METABOLISM;
D O I
10.1007/s10787-014-0217-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatic encephalopathy (HE) is a common complication of cirrhosis of the liver. It is also extremely debilitating, with an untreated 3-year survival of only 23 %. While the exact pathophysiology of HE has yet to be elucidated, a number of contributing factors have been described. Abnormal levels and altered metabolism of ammonia play a central role. Recently, inflammation has also been identified as a contributor to HE. Improved understanding of the pathophysiology of HE is crucial, as current therapy centers on reduction of the body's ammonia load. Lactulose is the first-line therapy for HE, with some antibiotics recently showing promise for improved outcomes in patients with HE. The role of anti-inflammatory therapies has yet to be evaluated.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 71 条
  • [1] Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy
    Agrawal, Amit
    Sharma, Barjesh Chander
    Sharma, Praveen
    Sarin, Shiv Kumar
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) : 1043 - 1050
  • [2] The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus
    Amodio, Piero
    Bemeur, Chantal
    Butterworth, Roger
    Cordoba, Juan
    Kato, Akinobu
    Montagnese, Sara
    Uribe, Misael
    Vilstrup, Hendrik
    Morgan, Marsha Y.
    [J]. HEPATOLOGY, 2013, 58 (01) : 325 - 336
  • [3] Mechanisms of hyperammonemia
    Bachmann, C
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (07) : 653 - 662
  • [4] Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
    Bajaj, Jasmohan S.
    Hylemon, Phillip B.
    Ridlon, Jason M.
    Heuman, Douglas M.
    Daita, Kalyani
    White, Melanie B.
    Monteith, Pamela
    Noble, Nicole A.
    Sikaroodi, Masoumeh
    Gillevet, Patrick M.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06): : G675 - G685
  • [5] Rifaximin Treatment in Hepatic Encephalopathy
    Bass, Nathan M.
    Mullen, Kevin D.
    Sanyal, Arun
    Poordad, Fred
    Neff, Guy
    Leevy, Carroll B.
    Sigal, Samuel
    Sheikh, Muhammad Y.
    Beavers, Kimberly
    Frederick, Todd
    Teperman, Lewis
    Hillebrand, Donald
    Huang, Shirley
    Merchant, Kunal
    Shaw, Audrey
    Bortey, Enoch
    Forbes, William P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (12) : 1071 - 1081
  • [6] DEAFNESS COMPLICATING ANTIBIOTIC THERAPY OF HEPATIC ENCEPHALOPATHY
    BERK, DP
    CHALMERS, T
    [J]. ANNALS OF INTERNAL MEDICINE, 1970, 73 (03) : 393 - +
  • [7] VEGETABLE VERSUS ANIMAL PROTEIN-DIET IN CIRRHOTIC-PATIENTS WITH CHRONIC ENCEPHALOPATHY - A RANDOMIZED CROSS-OVER COMPARISON
    BIANCHI, GP
    MARCHESINI, G
    FABBRI, A
    RONDELLI, A
    BUGIANESI, E
    ZOLI, M
    PISI, E
    [J]. JOURNAL OF INTERNAL MEDICINE, 1993, 233 (05) : 385 - 392
  • [8] Hepatic encephalopathy
    Blei, AT
    Córdoba, J
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) : 1968 - 1976
  • [9] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [10] Prognostic significance of hepatic encephalopathy in patients with cirrhosis
    Bustamante, J
    Rimola, A
    Ventura, PJ
    Navasa, M
    Cirera, I
    Reggiardo, V
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 890 - 895